Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sight Sciences (SGHT) Research & Development (2020 - 2025)

Sight Sciences has reported Research & Development over the past 6 years, most recently at $2.4 million for Q4 2025.

  • Quarterly results put Research & Development at $2.4 million for Q4 2025, down 43.23% from a year ago — trailing twelve months through Dec 2025 was $14.6 million (down 18.81% YoY), and the annual figure for FY2025 was $14.6 million, down 18.81%.
  • Research & Development for Q4 2025 was $2.4 million at Sight Sciences, down from $3.4 million in the prior quarter.
  • Over the last five years, Research & Development for SGHT hit a ceiling of $6.1 million in Q3 2022 and a floor of $2.4 million in Q4 2025.
  • Median Research & Development over the past 5 years was $4.4 million (2021), compared with a mean of $4.4 million.
  • Biggest five-year swings in Research & Development: skyrocketed 145.74% in 2021 and later tumbled 43.23% in 2025.
  • Sight Sciences' Research & Development stood at $4.4 million in 2021, then grew by 19.78% to $5.2 million in 2022, then plummeted by 34.51% to $3.4 million in 2023, then grew by 25.27% to $4.3 million in 2024, then tumbled by 43.23% to $2.4 million in 2025.
  • The last three reported values for Research & Development were $2.4 million (Q4 2025), $3.4 million (Q3 2025), and $4.4 million (Q2 2025) per Business Quant data.